RU | EN

 

Starting from January 1, 2021, registration of pharmaceuticals in five member countries of the Eurasian Economic Union (Armenia, Belarus, Kazakhstan, Kyrgyzstan, Russia) must be carried out in accordance with the corresponding regulatory requirements of the Eurasian Economic Union (the EAEU)*. Once a certain drug is approved in either of the countries of the EAEU, following a standard formality procedure it can be automatically approved in the rest of the countries of the union.

This removes the previously existing administrative barrier on the way to a full-fledged launch of the integrated market of pharmaceuticals in the EAEU countries and further emphasizes the importance and cost-efficiency of patent protection provided by Eurasian patents as compared to the bunch of the national patents in the above-mentioned countries.

In addition starting from March 1, 2021 the Eurasian Patent Office (the EAPO) has launched a pilot version of the EAPO Pharmaceutical Register, which allows to search for patents associated with certain drugs by their International Non-proprietary Names (INNs).

At the moment the register is available in Russian only on the official website of the EAPO at https://www.eapo.org/ru/patents/reestr/sfarma.php

Also the EAPO Pharmaceutical Register provides further technical data about

- legal status of the corresponding Eurasian patents in all member countries of the Eurasian Patent Convention (the EAPC);

- information on patent term extensions issued for the corresponding Eurasian patents in all member countries of the EAPC;

- registered marketing approvals as regards the corresponding drugs in all member countries of the EAPC**, which served as a ground for patent term extensions;

- information on registered licensing agreements with respect to the corresponding Eurasian patents in all member countries of the EAPC.

To sum up:
   

     1) the new Rules for registration and examination of pharmaceuticals in the EAEU countries would allow pharmaceutical manufacturers to expand market penetration in view of the simplified registration procedure.

     2) the EAPO Pharmaceutical register is aimed at facilitating a search of Eurasian patents by INNs of drugs and obtaining further relevant bibliographic information about the patents in question and drugs regulatory data in the EAPC-member states.

The Register is being currently under continuous development and the Eurasian Patent Office invites Eurasian patents owners to submit requests for including corresponding Eurasian patents into the EAPO Pharmaceutical Register.

We at Patentica will be happy to assist you with that and answer any further questions you may have. Please feel free to contact us for more details at This e-mail address is being protected from spambots. You need JavaScript enabled to view it. .